Feed MLEC
ML

Moolec Science S.A.

MLEC · NASDAQ

$6.41 +1.50% (+$0.09)
1M -22.64%
Market Cap $4.65M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9
Valuation
100 /100
Cheap
P/S 0.01x
P/E N/A
EV/FFO N/A
Growth
-
N/A
EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
13 /100
Weak
Gross margin 34.17%
FCF margin 9.02%
Net margin 33.41%
Quality
21 /100
Poor
ROIC 5.56%
Asset turnover 1.63x
ROA 54.45%
Debt
0 /100
High
Current ratio 0.13x
Int. coverage -2.18x
Debt/Equity N/A
Stability
6 /100
Unstable
Beta 0.26x
Profitable years 0
EPS volatility 4,916.31%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o MLEC
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Alejandro Antalich

Employees

103

Headquarters

Grand Cayman

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.